“INVESTIGATIONS ON CLINICAL VALIDATION OF MUTATED ZNF208 AS A NOVEL BIOMARKER OF BLAST CRISIS IN CHRONIC MYELOID LEUKEMIA”, J Popl Ther Clin Pharmacol, vol. 31, no. 9, pp. 1502–1518, Sep. 2024, doi: 10.53555/68zhqm37.